Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01773239 · ClinicalTrials.gov registry record · NA

Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia

A NA study, sponsored by Posit Science Corporation.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT01773239: Completed NA study, sponsored by Posit Science Corporation.

NCT01773239 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01773239, a NA study, has completed, sponsored by Posit Science Corporation.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The purpose of this study is to test a new computerized training program as well as to find out whether the computer training might help people who have schizophrenia. The investigators will study the effects of the computer training on how people with schizophrenia think about social interaction and on their social skills. At completion of training, TARA subjects will show improvement on measures of social cognition compared to their baseline performance.

Interventions

  • BEHAVIORAL TARA computer-based exercises

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2012-05
Est. Completion 2013-07
Phase NA
Posit Science Corporation

30 total trials

What the finished NCT01773239 record still lists

NCT01773239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which TARA computer-based exercises is the first listed.

NCT01773239 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01773239 about?

NCT01773239 is a clinical study titled "Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia". The purpose of this study is to test a new computerized training program as well as to find out whether the computer training might help people who have schizophrenia. The investigators will study the effects of the computer training on how people with schizophrenia think about social interaction an...

What is the current status of trial NCT01773239?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2012-05. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01773239?

The interventions under investigation include: TARA computer-based exercises (BEHAVIORAL).

Who is sponsoring clinical trial NCT01773239?

This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01773239's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01773239, the US trial registry maintained by the National Library of Medicine. NCT01773239 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.